<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>21(1)</volume><submitter>Hayakawa K</submitter><pubmed_abstract>Human old aged unmutated chronic lymphocytic leukemia U-CLL are the TCL1&lt;sup>+&lt;/sup>ZAP70&lt;sup>+&lt;/sup>CD5&lt;sup>+&lt;/sup> B cells. Since CD5 makes the BCR signaling tolerance, ZAP70 increased in U-CLL not only TCL1&lt;sup>+&lt;/sup> alone. In mice, TCL1 (TCL1A) is the negative from neonate to old aged, as TC&lt;sup>-&lt;/sup>. V&lt;sub>H&lt;/sub>8-12/V&lt;sub>k&lt;/sub>21-5 is the anti-thymocyte/Thy-1 autoreactive ATA B cell. When ATA μκTg generation in mice, ATA B cells are the neonate generated CD5&lt;sup>+&lt;/sup> B cells in B-1, and in the middle age, CD5&lt;sup>+&lt;/sup> can be down or continuously CD5&lt;sup>+&lt;/sup>, then, old aged CLL/lymphoma generation with increased CD11b in TC&lt;sup>-&lt;/sup>ZAP70&lt;sup>-&lt;/sup>CD5&lt;sup>-&lt;/sup> or TC&lt;sup>-&lt;/sup>ZAP70&lt;sup>+&lt;/sup>CD5&lt;sup>+&lt;/sup>. In this old aged TC&lt;sup>-&lt;/sup>ATA B microarray analysis showed most similar to human CLL and U-CLL, and TC&lt;sup>-&lt;/sup>ZAP70&lt;sup>+&lt;/sup>CD5&lt;sup>+&lt;/sup> showed certain higher present as U-CLL. Original neonate ATA B cells showed with several genes down or further increase in old aged tumor, and old aged T-bet&lt;sup>+&lt;/sup>CD11c&lt;sup>+&lt;/sup>, CTNNB1&lt;sup>hi&lt;/sup>, HMGB&lt;sup>hi&lt;/sup>, CXCR4&lt;sup>hi&lt;/sup>, DPP4&lt;sup>hi&lt;/sup> and decreased miR181b. These old aged increased genes and down miR181b are similar to human CLL. Also, in old age ATA B cell tumor, high CD38&lt;sup>++&lt;/sup>CD44&lt;sup>++&lt;/sup>, increased Ki67&lt;sup>+&lt;/sup> AID&lt;sup>+&lt;/sup>, and decreased CD180&lt;sup>-&lt;/sup> miR15O&lt;sup>low&lt;/sup> are similar to U-CLL. In this old aged ATA B, increased TLR7,9 and Wnt10b. TC&lt;sup>+&lt;/sup>Tg generated with ATAμκTg mice occurred middle age tumor as TC&lt;sup>+&lt;/sup>ZAP70&lt;sup>-&lt;/sup>CD5&lt;sup>+&lt;/sup> or TC&lt;sup>+&lt;/sup>ZAP70&lt;sup>+&lt;/sup>CD5&lt;sup>+&lt;/sup>, with high NF-kB1, TLR4,6 and Wnt5b,6 without increased CD11b. Since neonatal state to age with TC&lt;sup>+&lt;/sup>Tg continuously, middle age CLL/lymphoma generation is not similar to old aged generated, however, some increased in TC&lt;sup>+&lt;/sup>ZAP70&lt;sup>+&lt;/sup> are similar to the old age TC&lt;sup>-&lt;/sup> ATA B tumor. Then, TC&lt;sup>-&lt;/sup> ATA B old age tumor showed some difference to human CLL. ATA B cells showed CD11b&lt;sup>+&lt;/sup>CD22&lt;sup>++&lt;/sup>, CD24 down, and hepcidin Hamp2&lt;sup>++&lt;/sup> with iron down. This mouse V8-12 similar to human V2-5, and V2-5 showed several cancers with macrophages/neutrophils generated hepcidin&lt;sup>+&lt;/sup> iron&lt;sup>low&lt;/sup> or some showed hepcidin&lt;sup>-&lt;/sup> iron&lt;sup>+&lt;/sup> with tumor, and mouse V8-12 with different V&lt;sub>k&lt;/sub>19-17 generate MZ B cells strongly increased macrophage&lt;sup>++&lt;/sup> in old aged and generated intestine/colon tumor. Conclusion, neonate generated TC&lt;sup>-&lt;/sup>ATA B1 cells in old aged tumor generation are CD11b&lt;sup>+&lt;/sup> in the leukemia CLL together with lymphoma cancer with hepcidin-related Hamp2&lt;sup>++&lt;/sup> in B-1 cell generation to control iron.</pubmed_abstract><journal>Immunity &amp; ageing : I &amp; A</journal><pagination>22</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10988983</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice.</pubmed_title><pmcid>PMC10988983</pmcid><pubmed_authors>Shinton SA</pubmed_authors><pubmed_authors>Hayakawa K</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice.</name><description>Human old aged unmutated chronic lymphocytic leukemia U-CLL are the TCL1&lt;sup>+&lt;/sup>ZAP70&lt;sup>+&lt;/sup>CD5&lt;sup>+&lt;/sup> B cells. Since CD5 makes the BCR signaling tolerance, ZAP70 increased in U-CLL not only TCL1&lt;sup>+&lt;/sup> alone. In mice, TCL1 (TCL1A) is the negative from neonate to old aged, as TC&lt;sup>-&lt;/sup>. V&lt;sub>H&lt;/sub>8-12/V&lt;sub>k&lt;/sub>21-5 is the anti-thymocyte/Thy-1 autoreactive ATA B cell. When ATA μκTg generation in mice, ATA B cells are the neonate generated CD5&lt;sup>+&lt;/sup> B cells in B-1, and in the middle age, CD5&lt;sup>+&lt;/sup> can be down or continuously CD5&lt;sup>+&lt;/sup>, then, old aged CLL/lymphoma generation with increased CD11b in TC&lt;sup>-&lt;/sup>ZAP70&lt;sup>-&lt;/sup>CD5&lt;sup>-&lt;/sup> or TC&lt;sup>-&lt;/sup>ZAP70&lt;sup>+&lt;/sup>CD5&lt;sup>+&lt;/sup>. In this old aged TC&lt;sup>-&lt;/sup>ATA B microarray analysis showed most similar to human CLL and U-CLL, and TC&lt;sup>-&lt;/sup>ZAP70&lt;sup>+&lt;/sup>CD5&lt;sup>+&lt;/sup> showed certain higher present as U-CLL. Original neonate ATA B cells showed with several genes down or further increase in old aged tumor, and old aged T-bet&lt;sup>+&lt;/sup>CD11c&lt;sup>+&lt;/sup>, CTNNB1&lt;sup>hi&lt;/sup>, HMGB&lt;sup>hi&lt;/sup>, CXCR4&lt;sup>hi&lt;/sup>, DPP4&lt;sup>hi&lt;/sup> and decreased miR181b. These old aged increased genes and down miR181b are similar to human CLL. Also, in old age ATA B cell tumor, high CD38&lt;sup>++&lt;/sup>CD44&lt;sup>++&lt;/sup>, increased Ki67&lt;sup>+&lt;/sup> AID&lt;sup>+&lt;/sup>, and decreased CD180&lt;sup>-&lt;/sup> miR15O&lt;sup>low&lt;/sup> are similar to U-CLL. In this old aged ATA B, increased TLR7,9 and Wnt10b. TC&lt;sup>+&lt;/sup>Tg generated with ATAμκTg mice occurred middle age tumor as TC&lt;sup>+&lt;/sup>ZAP70&lt;sup>-&lt;/sup>CD5&lt;sup>+&lt;/sup> or TC&lt;sup>+&lt;/sup>ZAP70&lt;sup>+&lt;/sup>CD5&lt;sup>+&lt;/sup>, with high NF-kB1, TLR4,6 and Wnt5b,6 without increased CD11b. Since neonatal state to age with TC&lt;sup>+&lt;/sup>Tg continuously, middle age CLL/lymphoma generation is not similar to old aged generated, however, some increased in TC&lt;sup>+&lt;/sup>ZAP70&lt;sup>+&lt;/sup> are similar to the old age TC&lt;sup>-&lt;/sup> ATA B tumor. Then, TC&lt;sup>-&lt;/sup> ATA B old age tumor showed some difference to human CLL. ATA B cells showed CD11b&lt;sup>+&lt;/sup>CD22&lt;sup>++&lt;/sup>, CD24 down, and hepcidin Hamp2&lt;sup>++&lt;/sup> with iron down. This mouse V8-12 similar to human V2-5, and V2-5 showed several cancers with macrophages/neutrophils generated hepcidin&lt;sup>+&lt;/sup> iron&lt;sup>low&lt;/sup> or some showed hepcidin&lt;sup>-&lt;/sup> iron&lt;sup>+&lt;/sup> with tumor, and mouse V8-12 with different V&lt;sub>k&lt;/sub>19-17 generate MZ B cells strongly increased macrophage&lt;sup>++&lt;/sup> in old aged and generated intestine/colon tumor. Conclusion, neonate generated TC&lt;sup>-&lt;/sup>ATA B1 cells in old aged tumor generation are CD11b&lt;sup>+&lt;/sup> in the leukemia CLL together with lymphoma cancer with hepcidin-related Hamp2&lt;sup>++&lt;/sup> in B-1 cell generation to control iron.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2025-04-18T20:11:40.52Z</modification><creation>2025-04-07T08:06:17.419Z</creation></dates><accession>S-EPMC10988983</accession><cross_references><pubmed>38570827</pubmed><doi>10.1186/s12979-024-00415-6</doi></cross_references></HashMap>